SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QIAGEN (QGENF) - Star of Germany's Biotechs

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: JakeStraw7/20/2007 8:24:46 AM
   of 122
 
QIAGEN and the JCSG Announce Agreement for Commercialization of Sample Technologies for Protein Crystallography
biz.yahoo.com
Friday July 20, 12:40 am ET

VENLO, THE NETHERLANDS--(MARKET WIRE)--Jul 20, 2007 --

QIAGEN will supply proven, ready-to-use screening sets to determine protein structures

VENLO, The Netherlands / SAN DIEGO, CA, July 20, 2007 - QIAGEN N.V., the leading provider of sample and assay technologies for research in life sciences, molecular diagnostics and applied testing, today announced that it has entered a strategic agreement with the Joint Center for Structural Genomics (JCSG), one of the 4 PSI Structural Genomics Production Centers, providing protein crystallographers with a new set of proven crystallization screens that have been assembled from analysis of hundreds of thousands of crystallization experiments.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext